Skip to main content

News

April 07, 2020
Don't miss this special live presentation on Managing Interventional Oncology in the Time of COVID-19, featuring insight by #CIO2020 Course Director, Edward Kim, MD.
December 02, 2018
Long-term survival in patients with massive hepatocellular carcinomas was improved when treatment consisted of transcatheter arterial chemoembolization (TACE) combined with percutaneous microwave coagulation therapy compared with TACE alone.
November 26, 2018
No significant difference in overall survival and liver cancer-specific survival was found in patients with localized hepatocellular carcinoma treated with either cryoablation or radiofrequency ablation, according to a new study.
November 19, 2018
Transarterial radioembolization with yttrium-90 (TARE-Y90) of unresectable primary liver malignancy demonstrates an anticancer effect and could be used as adjunctive therapy in pediatric patients with unresectable hepatic malignancies.
November 19, 2018
Endovascular denervation can improve pain in patients with abdominal cancer and may offer a new approach to palliative care, according to a new study.
November 12, 2018
Results of a new study showed that AFP categories agreed moderately with mRECIST outcomes and yielded accurate prognostic prediction in patients with unresectable hepatocellular carcinoma and AFP levels ≥400 ng/mL treated with chemoembolization.
November 08, 2018
A concentrated dose of anti-CEA CAR-T cells administered precisely at the site of a solid tumor by Pressure-enabled Drug Delivery (PEDD) is safe, with encouraging clinical responses, according to the results of a phase 1b clinical trial.
November 05, 2018
In patients with ultrasound-invisible early stage hepatocellular carcinoma, the combined therapy of conventional transarterial chemoembolization followed by fluoroscopy-guided radiofrequency ablation was safe and effective resulting in less local…
October 31, 2018
A nomogram including 6 pre-Y90 radioembolization (RAE) parameters predicted overall survival (OS) post-RAE in patients with colorectal cancer liver metastases.
October 28, 2018
For the treatment of patients with unresectable hepatocellular carcinoma, the combination of TACE with iodine [131I] metuximab infusion may improve local efficacy and overall survival when compared with TACE alone.
October 21, 2018
A new study sought to determine if patient and facility demographics impacted overall survival in patients with early-stage non-small cell lung cancer treated with radiofrequency ablation.
Back to Top